Processa Pharmaceuticals Inc (PCSA)
2.17
-0.09
(-3.98%)
USD |
NASDAQ |
May 03, 16:00
2.20
+0.03
(+1.38%)
After-Hours: 20:00
Processa Pharmaceuticals Cash and Short Term Investments (Quarterly): 4.706M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.706M |
September 30, 2023 | 6.861M |
June 30, 2023 | 8.677M |
March 31, 2023 | 10.74M |
December 31, 2022 | 6.504M |
September 30, 2022 | 9.055M |
June 30, 2022 | 12.06M |
March 31, 2022 | 14.39M |
December 31, 2021 | 16.50M |
September 30, 2021 | 19.09M |
June 30, 2021 | 20.83M |
March 31, 2021 | 23.05M |
December 31, 2020 | 15.42M |
September 30, 2020 | 0.3254M |
June 30, 2020 | 0.4527M |
March 31, 2020 | 0.1423M |
December 31, 2019 | 0.6915M |
September 30, 2019 | 0.5043M |
June 30, 2019 | 0.722M |
March 31, 2019 | 1.248M |
December 31, 2018 | 1.741M |
September 30, 2018 | 2.424M |
June 30, 2018 | 3.347M |
Date | Value |
---|---|
March 31, 2018 | 1.777M |
December 31, 2017 | 2.847M |
September 30, 2017 | 0.0803M |
June 30, 2017 | 0.0019M |
March 31, 2017 | 0.0016M |
December 31, 2016 | 0.0032M |
September 30, 2016 | 0.0067M |
June 30, 2016 | 0.0149M |
March 31, 2016 | 0.0024M |
December 31, 2015 | 0.0021M |
September 30, 2015 | 0.0151M |
June 30, 2015 | 0.0152M |
March 31, 2015 | 0.0418M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.0557M |
June 30, 2014 | 0.0399M |
March 31, 2014 | 0.0822M |
December 31, 2013 | 0.1869M |
September 30, 2013 | 1.002M |
June 30, 2013 | 0.6298M |
March 31, 2013 | 0.4215M |
December 31, 2012 | 1.022M |
September 30, 2012 | 1.392M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.1423M
Minimum
Mar 2020
23.05M
Maximum
Mar 2021
8.986M
Average
8.677M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |
Theriva Biologics Inc | 23.18M |